| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.036 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |